# A28 Therapeutics
> Clinical-stage biopharmaceutical company developing targeted oncolytic peptides (TOPs) for treating cancer.

Basic company reference. Business areas, products and practical answers have not been added.

- Canonical entity: https://directory.readyscan.ai/entities/a28-therapeutics-q139829650
- Website listed in the source snapshot: https://www.a28therapeutics.com
- Category: [Pharmaceuticals](https://directory.readyscan.ai/directory/pharmaceuticals)
- Machine record: https://directory.readyscan.ai/discovery/entities/a28-therapeutics-q139829650.json
- Material fingerprint: fnv1a64:ca4e30c6fe186816
- Entity revision: fnv1a64:ae0ac04a616e6ba7
- Published: 2026-07-29
- Modified: 2026-07-29

## Company sources
- [A28 Therapeutics — Wikidata Q139829650](https://www.wikidata.org/wiki/Special:EntityData/Q139829650.json?revision=2493740168) — Wikidata

## Data access & reuse
- [Wikidata data access](https://www.wikidata.org/wiki/Help:Data_access) — Wikidata
- [Wikidata reuse permission](https://www.wikidata.org/wiki/Wikidata:Licensing) — Wikidata
- [CC0 1.0 Universal](https://creativecommons.org/publicdomain/zero/1.0/) — Wikidata

## Continue reading
- Discover the bounded graph: https://readyscan.ai/api/v1/ai-search/discovery
- Retrieve this entity evidence: https://readyscan.ai/api/v1/ai-search/entities/a28-therapeutics-q139829650/evidence

## Publication boundary
- This public-sourced record brings together company information and its sources. It is not an owner-managed profile.
- Publication does not guarantee crawling, indexing, training inclusion, citation, recommendation, referral, or revenue.